bexarotene has been researched along with Leukemia, Myeloid, Acute in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carroll, M; Glantz, ST; Kasner, MT; Sanchez, PV; Scotland, S | 1 |
| Arora, J; Cho, E; Espinoza-Delgado, I; Ferguson, A; Gore, SD; Greer, J; Jones, RJ; Kowalski, J; Matsui, WH; Norsworthy, KJ; Pratz, KW; Sakoian, S; Showel, M; Smith, BD; Sutherland, LA; Tsai, HL; Warlick, E | 1 |
| McNamara, S; Miller, WH | 1 |
| Andreadis, C; Bagg, A; Carroll, M; Goldstein, SC; Goradia, A; Kemner, A; Loren, AW; Luger, SM; Mato, AR; Perl, AE; Porter, DL; Potuzak, M; Schuster, SJ; Stadtmauer, EA; Swider, C; Thompson, JE; Tsai, DE; Vogl, DT | 1 |
| Andea, A; Hughey, LC; Stewart, FA | 1 |
2 trial(s) available for bexarotene and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Differentiation therapy in poor risk myeloid malignancies: Results of companion phase II studies.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Bexarotene; Female; Granulocyte-Macrophage Colony-Stimulating Factor; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Neutrophils; Pyridines; Recombinant Proteins; Remission Induction; Salvage Therapy; Tetrahydronaphthalenes; Treatment Outcome; U937 Cells | 2016 |
A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 acute myeloid leukemia.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Bexarotene; Female; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Male; Maximum Tolerated Dose; Middle Aged; Retinoid X Receptors; Tetrahydronaphthalenes | 2008 |
3 other study(ies) available for bexarotene and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Induced differentiation of acute myeloid leukemia cells by activation of retinoid X and liver X receptors.
Topics: Bexarotene; CCAAT-Enhancer-Binding Protein-alpha; CCAAT-Enhancer-Binding Proteins; Cell Differentiation; Cell Line, Tumor; Humans; Hydrocarbons, Fluorinated; Leukemia, Myeloid, Acute; Liver X Receptors; Nicotinic Acids; Orphan Nuclear Receptors; Proto-Oncogene Proteins; Retinoid X Receptors; Sulfonamides; Tetrahydronaphthalenes; Trans-Activators; Tretinoin | 2014 |
Expanding the use of retinoids in acute myeloid leukemia: spotlight on bexarotene.
Topics: Bexarotene; Clinical Trials as Topic; Epigenesis, Genetic; Humans; Leukemia, Myeloid, Acute; Maximum Tolerated Dose; Retinoid X Receptors; Retinoids; Signal Transduction; Tetrahydronaphthalenes | 2008 |
Mycosis fungoides-associated follicular mucinosis after bone-marrow transplantation.
Topics: Adult; Anticarcinogenic Agents; Bexarotene; Bone Marrow Transplantation; Fatal Outcome; Female; Humans; Leukemia, Myeloid, Acute; Mucinosis, Follicular; Mycosis Fungoides; Tetrahydronaphthalenes | 2012 |